191 related articles for article (PubMed ID: 30160667)
1. [Primary-progressive multiple sclerosis in Russia: a medical-sociological study involving patients and neurologists].
Vlasov YV; Churakov MV; Kurapov MA; Gromova TN; Popova EV; Boyko OV; Spirin NN; Sivertseva SA; Belskaya GN; Malkova NA; Habirov FA; Haybullin TI; Kotov SV; Greshnova IV; Ivashinenkova EI; Bakalova MA; Yampolskaya-Gosteva IA; Boyko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8. Vyp. 2):40-46. PubMed ID: 30160667
[TBL] [Abstract][Full Text] [Related]
2. Survey of diagnostic and treatment practices for multiple sclerosis in Russian Federation in comparison to European data.
Boykо A; Fernández O; Alifirova V; Babicheva N; Bakhtiyarova K; Volkov A; Glavinskaya N; Goncharova Z; Greshnova I; Smagina I; Lashch N; Inzhinova A; Karnaukh V; Lukashevich I; Malkova N; Poverennova I; Sivertseva S; Sinitsina L; Khoroshilova N; Sherman M; Shchur S; Yampolskaya-Gosteva I; Melnikov M; Lozovskaya I
Mult Scler Relat Disord; 2021 Oct; 55():103201. PubMed ID: 34391041
[TBL] [Abstract][Full Text] [Related]
3. [Radiologically isolated syndrome as a possible preclinical stage of primary-progressive multiple sclerosis].
Popova EV; Bryukhov VV; Boyko AN; Krotenkova MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8. Vyp. 2):35-39. PubMed ID: 30160666
[TBL] [Abstract][Full Text] [Related]
4. [Primary progressive multiple sclerosis: current issues of timely diagnosis].
Popova EV; Boyko AN; Barabanova MA; Antipova LN; Bakhtiyarova KZ; Belova AN; Solovieva VS; Belskaya GN; Lukashevich IG; Nikolaeva LI; Volkova LI; Turova EL; Kraeva AV; Goncharova ZA; Malkova NA; Poverennova IE; Sivertseva SA; Zhelnin AV; Trushnikova TN; Khabirov FA; Khaibullin TI
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10. Vyp. 2):35-40. PubMed ID: 29359731
[TBL] [Abstract][Full Text] [Related]
5. [Sociological research in Samara Oblast: a role of social organizations of patients in the improvement of quality of medical and social care].
Gromova TN; Kurapov MA; Sineok EV; Vlasov IaV; Churakov MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2 Pt 2):104-11. PubMed ID: 22737766
[TBL] [Abstract][Full Text] [Related]
6. [Polymorphic variants of the immune response genes as risk factors for primary progressive multiple sclerosis].
Popova EV; Kiselev IS; Boyko AN; Sivertseva SA; Malkova NA; Korobko DS; Spirin NN; Kasatkin DS; Karaeva AV; Turova EL; Spirina NN; Volkova LI; Baulina NM; Bashinskaya VV; Kulakova OG; Favorova OO
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2. Vyp. 2):14-21. PubMed ID: 28617357
[TBL] [Abstract][Full Text] [Related]
7. Patients and neurologists have different perceptions of multiple sclerosis symptoms, care and challenges.
Marin CE; Kfouri PP; Callegaro D; Lana-Peixoto MA; Neto APG; Vasconcelos CCF; d'Almeida JAC; Gonçalves MVM; Mendes MF; Parolin MKF; Nascimento O; da Gama PD; Dias-Carneiro RPC; Dias RM; Damasceno A; San Martin G; Becker J;
Mult Scler Relat Disord; 2021 May; 50():102806. PubMed ID: 33588316
[TBL] [Abstract][Full Text] [Related]
8. [The quality of medical care of patients with amyotrophic lateral sclerosis in the Russian Federation].
Levitsky GN; Chub RV; Kryachkov AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(6):72-75. PubMed ID: 30040804
[TBL] [Abstract][Full Text] [Related]
9. Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management.
Fernández O; Delvecchio M; Edan G; Fredrikson S; Giovannoni G; Hartung HP; Havrdova E; Kappos L; Pozzilli C; Soerensen PS; Tackenberg B; Vermersch P; Comi G
Eur J Neurol; 2018 May; 25(5):739-746. PubMed ID: 29356206
[TBL] [Abstract][Full Text] [Related]
10. [The quality of medical care and cooperation of patients with amyotrophic lateral sclerosis in the Russian Federation].
Levitsky GN; Chub RV; Kryachkov AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(1. Vyp. 2):59-63. PubMed ID: 28514335
[TBL] [Abstract][Full Text] [Related]
11. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
Galego O; Gouveia A; Batista S; Moura C; Machado E
Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
[TBL] [Abstract][Full Text] [Related]
12. [The resolution of the expert body for the section on demyelinating diseases of the Russian Society of Neurologists and Russian Executive Committee of multiple sclerosis researchers (Kazan, 19 november 2015) on the 'Current principles and optimization of treatment of patients with relapsing-remitting multiple sclerosis with glatiramer acetate'].
Redaktsiia
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(2 Pt 2):78-79. PubMed ID: 28635770
[No Abstract] [Full Text] [Related]
13. Interferon beta for primary progressive multiple sclerosis.
Rojas JI; Romano M; Ciapponi A; Patrucco L; Cristiano E
Cochrane Database Syst Rev; 2009 Jan; (1):CD006643. PubMed ID: 19160292
[TBL] [Abstract][Full Text] [Related]
14. [A current view on the MRI diagnosis of multiple sclerosis: an update of 2016 revised MRI criteria].
Bryukhov VV; Krotenkova IA; Morozova SN; Krotenkova MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2. Vyp. 2):66-73. PubMed ID: 28617364
[TBL] [Abstract][Full Text] [Related]
15. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
[TBL] [Abstract][Full Text] [Related]
16. Dietary risk factors of primary progressive multiple sclerosis: A population-based case-control study.
Rezaeimanesh N; Moghadasi AN; Sahraian MA; Eskandarieh S
Mult Scler Relat Disord; 2021 Nov; 56():103233. PubMed ID: 34488182
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
[TBL] [Abstract][Full Text] [Related]
18. Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Antel J; Antel S; Caramanos Z; Arnold DL; Kuhlmann T
Acta Neuropathol; 2012 May; 123(5):627-38. PubMed ID: 22327362
[TBL] [Abstract][Full Text] [Related]
19. A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study.
Westerlind H; Stawiarz L; Fink K; Hillert J; Manouchehrinia A
Mult Scler; 2016 Jul; 22(8):1071-9. PubMed ID: 27072687
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.
Sumelahti ML; Tienari PJ; Hakama M; Wikström J
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):25-8. PubMed ID: 12486261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
